CN108697782A - 针对pcv2病毒和猪肺炎支原体感染的组合疫苗 - Google Patents

针对pcv2病毒和猪肺炎支原体感染的组合疫苗 Download PDF

Info

Publication number
CN108697782A
CN108697782A CN201780014561.9A CN201780014561A CN108697782A CN 108697782 A CN108697782 A CN 108697782A CN 201780014561 A CN201780014561 A CN 201780014561A CN 108697782 A CN108697782 A CN 108697782A
Authority
CN
China
Prior art keywords
vaccine
pcv2
immunogene
mycoplasma hyopneumoniae
replicating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201780014561.9A
Other languages
English (en)
Chinese (zh)
Inventor
M.斯诺
M.H.维特弗利耶
V.法辛格尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Intervet International BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet International BV filed Critical Intervet International BV
Publication of CN108697782A publication Critical patent/CN108697782A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
CN201780014561.9A 2016-03-23 2017-03-22 针对pcv2病毒和猪肺炎支原体感染的组合疫苗 Pending CN108697782A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16161997 2016-03-23
EP16161997.8 2016-03-23
PCT/EP2017/056831 WO2017162741A1 (en) 2016-03-23 2017-03-22 A combination vaccine against pcv2 virus and mycoplasma hyopneumoniae infection

Publications (1)

Publication Number Publication Date
CN108697782A true CN108697782A (zh) 2018-10-23

Family

ID=55589754

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201780014561.9A Pending CN108697782A (zh) 2016-03-23 2017-03-22 针对pcv2病毒和猪肺炎支原体感染的组合疫苗

Country Status (7)

Country Link
US (1) US20190105385A1 (https=)
EP (1) EP3432919A1 (https=)
JP (1) JP6907227B2 (https=)
CN (1) CN108697782A (https=)
BR (1) BR112018069100A2 (https=)
RU (1) RU2018137034A (https=)
WO (1) WO2017162741A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114364398A (zh) * 2019-09-12 2022-04-15 英特维特国际股份有限公司 用于皮内施用的联合疫苗
CN115887636A (zh) * 2022-01-18 2023-04-04 武汉科前生物股份有限公司 猪圆环病毒2型、猪肺炎支原体、猪链球菌三联灭活疫苗及其制备方法

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020011044A2 (pt) * 2017-12-04 2020-11-17 Intervet International B.V. vacinação com partículas de replicon e adjuvante de óleo
JP7510874B2 (ja) * 2017-12-22 2024-07-04 ヒプラ シエンティフィック エセ．エレ．ウ． マイコプラズマ及びブタサーコウイルスに対する皮内混合ワクチン
KR20230004654A (ko) * 2020-04-20 2023-01-06 인터벳 인터내셔널 비.브이. 마이코플라즈마 하이오뉴모니아에로부터 방어하기 위한 백신
CA3176154A1 (en) 2020-04-20 2021-10-28 Maarten Hendrik Witvliet A combination of vaccines to prophylactically treat a pig
WO2025132513A1 (en) 2023-12-19 2025-06-26 Intervet International B.V. Low-energy electron irradiation-inactivated mollicutes

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050220814A1 (en) * 2004-04-05 2005-10-06 Dominowski Paul J Microfluidized oil-in-water emulsions and vaccine compositions
WO2007006939A2 (fr) * 2005-07-07 2007-01-18 Sanofi Pasteur Emulsion immuno-adjuvante thermoreversible
CN102006884A (zh) * 2008-04-18 2011-04-06 英特威国际有限公司 防御胞内劳森菌、猪肺炎支原体和猪圆环病毒的疫苗
CN103263666A (zh) * 2013-05-24 2013-08-28 北京大北农科技集团股份有限公司动物医学研究中心 猪圆环病毒2型、猪支原体肺炎二联灭活疫苗及其制备方法
CN104043118A (zh) * 2013-03-11 2014-09-17 普莱柯生物工程股份有限公司 猪prrsv、猪肺炎支原体和pvc-2抗原在制备疫苗中的应用
CN104271153A (zh) * 2012-04-04 2015-01-07 硕腾有限责任公司 Pcv/猪肺炎支原体/prrs组合疫苗
CN104334186A (zh) * 2012-04-04 2015-02-04 硕腾有限责任公司 Pcv/猪肺炎支原体组合疫苗

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU212924B (en) * 1989-05-25 1996-12-30 Chiron Corp Adjuvant formulation comprising a submicron oil droplet emulsion
SI1651265T1 (sl) * 2003-07-24 2008-10-31 Merial Ltd Formulacije cepiva, ki obsegajo emulzijo olje v vodi
RU2007130801A (ru) 2005-01-13 2009-02-20 Берингер Ингельхайм Ветмедика Гмбх (De) Улучшенные вакцины против репродуктивно-респираторного синдрома свиней (prrs)
US8834891B2 (en) * 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
ES2425228T3 (es) 2005-09-09 2013-10-14 Intervet International B.V. Vacuna contra el PCV-2
DK3766518T3 (da) 2005-12-29 2026-04-13 Boehringer Ingelheim Animal Health Usa Inc Immunogen pcv2-sammensætning til mindskelse af kliniske symptomer hos grise
PT2094872T (pt) 2006-12-15 2017-04-27 Boehringer Ingelheim Vetmedica Inc Tratamento de porcos seropositivos para o anticorpo anti-pcv2 com antigénio de pcv2
US8728487B2 (en) 2011-01-20 2014-05-20 Hua Wu Attenuated live vaccine for prevention of porcine reproductive and respiratory syndrome
JP6460792B2 (ja) * 2011-09-09 2019-01-30 ナノバイオ コーポレーション ナノエマルション呼吸器合胞体ウイルス（ｒｓｖ）サブユニットワクチン
US9457073B2 (en) 2012-09-26 2016-10-04 University Of Manitoba Live attenuated replication-competent arteriviruses having decreased dub/deisgylating activity
KR102547168B1 (ko) * 2013-12-03 2023-06-22 인터벳 인터내셔널 비.브이. 로소니아 인트라셀룰라리스 및 돼지 써코바이러스 2에 대한 백신

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050220814A1 (en) * 2004-04-05 2005-10-06 Dominowski Paul J Microfluidized oil-in-water emulsions and vaccine compositions
CN1997390A (zh) * 2004-04-05 2007-07-11 辉瑞产品有限公司 微流化水包油乳状液和疫苗组合物
WO2007006939A2 (fr) * 2005-07-07 2007-01-18 Sanofi Pasteur Emulsion immuno-adjuvante thermoreversible
CN102006884A (zh) * 2008-04-18 2011-04-06 英特威国际有限公司 防御胞内劳森菌、猪肺炎支原体和猪圆环病毒的疫苗
CN104271153A (zh) * 2012-04-04 2015-01-07 硕腾有限责任公司 Pcv/猪肺炎支原体/prrs组合疫苗
CN104334186A (zh) * 2012-04-04 2015-02-04 硕腾有限责任公司 Pcv/猪肺炎支原体组合疫苗
JP2015512450A (ja) * 2012-04-04 2015-04-27 ゾエティス・エルエルシー Ｐｃｖ／マイコプラズマ・ハイオニューモニエ／ｐｒｒｓ混合ワクチン
CN104043118A (zh) * 2013-03-11 2014-09-17 普莱柯生物工程股份有限公司 猪prrsv、猪肺炎支原体和pvc-2抗原在制备疫苗中的应用
CN103263666A (zh) * 2013-05-24 2013-08-28 北京大北农科技集团股份有限公司动物医学研究中心 猪圆环病毒2型、猪支原体肺炎二联灭活疫苗及其制备方法

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114364398A (zh) * 2019-09-12 2022-04-15 英特维特国际股份有限公司 用于皮内施用的联合疫苗
CN115887636A (zh) * 2022-01-18 2023-04-04 武汉科前生物股份有限公司 猪圆环病毒2型、猪肺炎支原体、猪链球菌三联灭活疫苗及其制备方法

Also Published As

Publication number Publication date
JP2019509300A (ja) 2019-04-04
RU2018137034A3 (https=) 2020-06-26
EP3432919A1 (en) 2019-01-30
BR112018069100A2 (pt) 2019-01-29
WO2017162741A1 (en) 2017-09-28
JP6907227B2 (ja) 2021-07-21
RU2018137034A (ru) 2020-04-23
US20190105385A1 (en) 2019-04-11

Similar Documents

Publication Publication Date Title
CN108697782A (zh) 针对pcv2病毒和猪肺炎支原体感染的组合疫苗
KR102003620B1 (ko) Pcv/마이코플라즈마 하이요뉴모니아 조합 백신
EP3558351B1 (en) Combination vaccine for swine
US11744883B2 (en) Intradermal combination vaccine against mycoplasma and porcine circovirus
CN114364398B (zh) 用于皮内施用的联合疫苗
JP2023025210A (ja) 組合せ非混合使用のためのブタ病原体含有ワクチン
US11654191B2 (en) Vaccine for intradermal application against PCV2 and PRRS virus infection
CN115427072A (zh) 预防性治疗猪的疫苗组合
US10953084B2 (en) Combination vaccine against PCV2 and PRRS virus infection comprising albumin
RU2834834C1 (ru) Комбинация вакцин для профилактического лечения свиней

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination